A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
about
A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Prospective Study to Assess ...... cular Hypertension or Glaucoma
@en
type
label
A Prospective Study to Assess ...... cular Hypertension or Glaucoma
@en
prefLabel
A Prospective Study to Assess ...... cular Hypertension or Glaucoma
@en
P1050
P1476
A Prospective Study to Assess ...... cular Hypertension or Glaucoma
@en
P1813
ROCK
@en
P3098
NCT01936389
P580
2013-09-01T00:00:00Z
P582
2014-10-01T00:00:00Z